Several investigators in Vanderbilt-Ingram Cancer Center’s (VICC) Breast Cancer Program have received grant awards to support translational research that may improve disease outcomes for patients.
Rene Raphemot, Ph.D., a National Institutes of Health postdoctoral fellow at Duke University, delivered the inaugural Discovery Science Emerging Scholars Lecture at Vanderbilt University School of Medicine last week.
Interventions for delirium in the emergency department setting are needed to preserve patients’ long-term function and cognition, Vanderbilt investigators have found.
A gluten-free diet is not a weight-loss solution. Here’s what it treats and how.
Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.
The Tennessee Ambulance Service Association (TASA) has named Vanderbilt LifeFlight’s Jeremy Brywczynski, M.D., as the medical director of the year for the statewide ambulance association.
Accessibility Tools